Ocugen Inc (OCGN)
0.805
0.00 (0.00%)
USD |
NASDAQ |
Dec 31, 16:00
0.81
0.00 (0.00%)
After-Hours: 20:00
Ocugen Research and Development Expense (Quarterly): 8.108M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Cytokinetics Inc | -- |
Insmed Inc | 150.81M |
Scholar Rock Holding Corp | 48.72M |
Mirum Pharmaceuticals Inc | 31.71M |
MetaVia Inc | 4.517M |